 | • レポートコード：GIR-2104Z10833 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、薬物動態サービスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。薬物動態サービスの種類別市場規模（小分子薬物動態サービス、大分子（バイオ医薬品）薬物動態サービス）、用途別市場規模（中小企業、大企業）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・薬物動態サービスの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Evotec AG (Germany)、Pacific BioLabs (US)、GVK Biosciences Private Limited (India)、Shanghai Medicilon Inc. (China)、Pharmaceutical Product Development, LLC (US)、Charles River Laboratories International, Inc. (US)、PAREXEL International Corporation (US)、Eurofins Scientific, Inc. (Luxembourg)、Frontage Labs (US)、SGS SA (Switzerland)、LGC Limited (UK)、Creative Bioarray (US)、Certara, L.P. (Germany) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：小分子薬物動態サービス、大分子（バイオ医薬品）薬物動態サービス ・用途別分析2016年-2026年：中小企業、大企業 ・薬物動態サービスの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・薬物動態サービスのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・薬物動態サービスのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・薬物動態サービスの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・薬物動態サービスの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pharmacokinetics Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pharmacokinetics Services size is estimated to be USD 749 million in 2025 from USD 628 million in 2019, with a change XX% between 2019 and 2020. The global Pharmacokinetics Services market size is expected to grow at a CAGR of 4.5% for the next five years.
Market segmentation
Pharmacokinetics Services market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Market segment by Application, can be divided into
Small & Medium Enterprise
Large Enterprise
Market segment by players, this report covers
Evotec AG (Germany)
Pacific BioLabs (US)
GVK Biosciences Private Limited (India)
Shanghai Medicilon Inc. (China)
Pharmaceutical Product Development, LLC (US)
Charles River Laboratories International, Inc. (US)
PAREXEL International Corporation (US)
Eurofins Scientific, Inc. (Luxembourg)
Frontage Labs (US)
SGS SA (Switzerland)
LGC Limited (UK)
Creative Bioarray (US)
Certara, L.P. (Germany)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Pharmacokinetics Services
1.2 Classification of Pharmacokinetics Services by Type
1.2.1 Overview: Global Pharmacokinetics Services Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Pharmacokinetics Services Revenue Market Share by Type in 2020
1.2.3 Small Molecules Pharmacokinetics Services
1.2.4 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
1.3 Global Pharmacokinetics Services Market by Application
1.3.1 Overview: Global Pharmacokinetics Services Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Small & Medium Enterprise
1.3.3 Large Enterprise
1.4 Global Pharmacokinetics Services Market Size & Forecast
1.5 Global Pharmacokinetics Services Market Size and Forecast by Region
1.5.1 Global Pharmacokinetics Services Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Pharmacokinetics Services Market Size by Region, (2016-2021)
1.5.3 North America Pharmacokinetics Services Market Size and Prospect (2016-2026)
1.5.4 Europe Pharmacokinetics Services Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Pharmacokinetics Services Market Size and Prospect (2016-2026)
1.5.6 South America Pharmacokinetics Services Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Pharmacokinetics Services Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmacokinetics Services Market Drivers
1.6.2 Pharmacokinetics Services Market Restraints
1.6.3 Pharmacokinetics Services Trends Analysis
2 Company Profiles
2.1 Evotec AG (Germany)
2.1.1 Evotec AG (Germany) Details
2.1.2 Evotec AG (Germany) Major Business
2.1.3 Evotec AG (Germany) Pharmacokinetics Services Product and Solutions
2.1.4 Evotec AG (Germany) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Evotec AG (Germany) Recent Developments and Future Plans
2.2 Pacific BioLabs (US)
2.2.1 Pacific BioLabs (US) Details
2.2.2 Pacific BioLabs (US) Major Business
2.2.3 Pacific BioLabs (US) Pharmacokinetics Services Product and Solutions
2.2.4 Pacific BioLabs (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pacific BioLabs (US) Recent Developments and Future Plans
2.3 GVK Biosciences Private Limited (India)
2.3.1 GVK Biosciences Private Limited (India) Details
2.3.2 GVK Biosciences Private Limited (India) Major Business
2.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Product and Solutions
2.3.4 GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GVK Biosciences Private Limited (India) Recent Developments and Future Plans
2.4 Shanghai Medicilon Inc. (China)
2.4.1 Shanghai Medicilon Inc. (China) Details
2.4.2 Shanghai Medicilon Inc. (China) Major Business
2.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product and Solutions
2.4.4 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Shanghai Medicilon Inc. (China) Recent Developments and Future Plans
2.5 Pharmaceutical Product Development, LLC (US)
2.5.1 Pharmaceutical Product Development, LLC (US) Details
2.5.2 Pharmaceutical Product Development, LLC (US) Major Business
2.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product and Solutions
2.5.4 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Pharmaceutical Product Development, LLC (US) Recent Developments and Future Plans
2.6 Charles River Laboratories International, Inc. (US)
2.6.1 Charles River Laboratories International, Inc. (US) Details
2.6.2 Charles River Laboratories International, Inc. (US) Major Business
2.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product and Solutions
2.6.4 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Charles River Laboratories International, Inc. (US) Recent Developments and Future Plans
2.7 PAREXEL International Corporation (US)
2.7.1 PAREXEL International Corporation (US) Details
2.7.2 PAREXEL International Corporation (US) Major Business
2.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Product and Solutions
2.7.4 PAREXEL International Corporation (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 PAREXEL International Corporation (US) Recent Developments and Future Plans
2.8 Eurofins Scientific, Inc. (Luxembourg)
2.8.1 Eurofins Scientific, Inc. (Luxembourg) Details
2.8.2 Eurofins Scientific, Inc. (Luxembourg) Major Business
2.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product and Solutions
2.8.4 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Developments and Future Plans
2.9 Frontage Labs (US)
2.9.1 Frontage Labs (US) Details
2.9.2 Frontage Labs (US) Major Business
2.9.3 Frontage Labs (US) Pharmacokinetics Services Product and Solutions
2.9.4 Frontage Labs (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Frontage Labs (US) Recent Developments and Future Plans
2.10 SGS SA (Switzerland)
2.10.1 SGS SA (Switzerland) Details
2.10.2 SGS SA (Switzerland) Major Business
2.10.3 SGS SA (Switzerland) Pharmacokinetics Services Product and Solutions
2.10.4 SGS SA (Switzerland) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 SGS SA (Switzerland) Recent Developments and Future Plans
2.11 LGC Limited (UK)
2.11.1 LGC Limited (UK) Details
2.11.2 LGC Limited (UK) Major Business
2.11.3 LGC Limited (UK) Pharmacokinetics Services Product and Solutions
2.11.4 LGC Limited (UK) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 LGC Limited (UK) Recent Developments and Future Plans
2.12 Creative Bioarray (US)
2.12.1 Creative Bioarray (US) Details
2.12.2 Creative Bioarray (US) Major Business
2.12.3 Creative Bioarray (US) Pharmacokinetics Services Product and Solutions
2.12.4 Creative Bioarray (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Creative Bioarray (US) Recent Developments and Future Plans
2.13 Certara, L.P. (Germany)
2.13.1 Certara, L.P. (Germany) Details
2.13.2 Certara, L.P. (Germany) Major Business
2.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Product and Solutions
2.13.4 Certara, L.P. (Germany) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Certara, L.P. (Germany) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pharmacokinetics Services Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Pharmacokinetics Services Players Market Share
3.2.2 Top 10 Pharmacokinetics Services Players Market Share
3.2.3 Market Competition Trend
3.3 Pharmacokinetics Services Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Pharmacokinetics Services Revenue and Market Share by Type (2016-2021)
4.2 Global Pharmacokinetics Services Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Pharmacokinetics Services Revenue Market Share by Application (2016-2021)
5.2 Pharmacokinetics Services Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Pharmacokinetics Services Revenue by Type (2016-2026)
6.2 North America Pharmacokinetics Services Revenue by Application (2016-2026)
6.3 North America Pharmacokinetics Services Market Size by Country
6.3.1 North America Pharmacokinetics Services Revenue by Country (2016-2026)
6.3.2 United States Pharmacokinetics Services Market Size and Forecast (2016-2026)
6.3.3 Canada Pharmacokinetics Services Market Size and Forecast (2016-2026)
6.3.4 Mexico Pharmacokinetics Services Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Pharmacokinetics Services Revenue by Type (2016-2026)
7.2 Europe Pharmacokinetics Services Revenue by Application (2016-2026)
7.3 Europe Pharmacokinetics Services Market Size by Country
7.3.1 Europe Pharmacokinetics Services Revenue by Country (2016-2026)
7.3.2 Germany Pharmacokinetics Services Market Size and Forecast (2016-2026)
7.3.3 France Pharmacokinetics Services Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Pharmacokinetics Services Market Size and Forecast (2016-2026)
7.3.5 Russia Pharmacokinetics Services Market Size and Forecast (2016-2026)
7.3.6 Italy Pharmacokinetics Services Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pharmacokinetics Services Revenue by Type (2016-2026)
8.2 Asia-Pacific Pharmacokinetics Services Revenue by Application (2016-2026)
8.3 Asia-Pacific Pharmacokinetics Services Market Size by Region
8.3.1 Asia-Pacific Pharmacokinetics Services Revenue by Region (2016-2026)
8.3.2 China Pharmacokinetics Services Market Size and Forecast (2016-2026)
8.3.3 Japan Pharmacokinetics Services Market Size and Forecast (2016-2026)
8.3.4 South Korea Pharmacokinetics Services Market Size and Forecast (2016-2026)
8.3.5 India Pharmacokinetics Services Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Pharmacokinetics Services Market Size and Forecast (2016-2026)
8.3.7 Australia Pharmacokinetics Services Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Pharmacokinetics Services Revenue by Type (2016-2026)
9.2 South America Pharmacokinetics Services Revenue by Application (2016-2026)
9.3 South America Pharmacokinetics Services Market Size by Country
9.3.1 South America Pharmacokinetics Services Revenue by Country (2016-2026)
9.3.2 Brazil Pharmacokinetics Services Market Size and Forecast (2016-2026)
9.3.3 Argentina Pharmacokinetics Services Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pharmacokinetics Services Revenue by Type (2016-2026)
10.2 Middle East & Africa Pharmacokinetics Services Revenue by Application (2016-2026)
10.3 Middle East & Africa Pharmacokinetics Services Market Size by Country
10.3.1 Middle East & Africa Pharmacokinetics Services Revenue by Country (2016-2026)
10.3.2 Turkey Pharmacokinetics Services Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Pharmacokinetics Services Market Size and Forecast (2016-2026)
10.3.4 UAE Pharmacokinetics Services Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Pharmacokinetics Services Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Pharmacokinetics Services Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Pharmacokinetics Services Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Pharmacokinetics Services Revenue (USD Million) by Region (2016-2021)
Table 5. Global Pharmacokinetics Services Revenue Market Share by Region (2021-2026)
Table 6. Evotec AG (Germany) Corporate Information, Head Office, and Major Competitors
Table 7. Evotec AG (Germany) Major Business
Table 8. Evotec AG (Germany) Pharmacokinetics Services Product and Solutions
Table 9. Evotec AG (Germany) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pacific BioLabs (US) Corporate Information, Head Office, and Major Competitors
Table 11. Pacific BioLabs (US) Major Business
Table 12. Pacific BioLabs (US) Pharmacokinetics Services Product and Solutions
Table 13. Pacific BioLabs (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GVK Biosciences Private Limited (India) Corporate Information, Head Office, and Major Competitors
Table 15. GVK Biosciences Private Limited (India) Major Business
Table 16. GVK Biosciences Private Limited (India) Pharmacokinetics Services Product and Solutions
Table 17. GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Shanghai Medicilon Inc. (China) Corporate Information, Head Office, and Major Competitors
Table 19. Shanghai Medicilon Inc. (China) Major Business
Table 20. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Product and Solutions
Table 21. Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Pharmaceutical Product Development, LLC (US) Corporate Information, Head Office, and Major Competitors
Table 23. Pharmaceutical Product Development, LLC (US) Major Business
Table 24. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product and Solutions
Table 25. Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Charles River Laboratories International, Inc. (US) Corporate Information, Head Office, and Major Competitors
Table 27. Charles River Laboratories International, Inc. (US) Major Business
Table 28. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Product and Solutions
Table 29. Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. PAREXEL International Corporation (US) Corporate Information, Head Office, and Major Competitors
Table 31. PAREXEL International Corporation (US) Major Business
Table 32. PAREXEL International Corporation (US) Pharmacokinetics Services Product and Solutions
Table 33. PAREXEL International Corporation (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Eurofins Scientific, Inc. (Luxembourg) Corporate Information, Head Office, and Major Competitors
Table 35. Eurofins Scientific, Inc. (Luxembourg) Major Business
Table 36. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Product and Solutions
Table 37. Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Frontage Labs (US) Corporate Information, Head Office, and Major Competitors
Table 39. Frontage Labs (US) Major Business
Table 40. Frontage Labs (US) Pharmacokinetics Services Product and Solutions
Table 41. Frontage Labs (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. SGS SA (Switzerland) Corporate Information, Head Office, and Major Competitors
Table 43. SGS SA (Switzerland) Major Business
Table 44. SGS SA (Switzerland) Pharmacokinetics Services Product and Solutions
Table 45. SGS SA (Switzerland) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. LGC Limited (UK) Corporate Information, Head Office, and Major Competitors
Table 47. LGC Limited (UK) Major Business
Table 48. LGC Limited (UK) Pharmacokinetics Services Product and Solutions
Table 49. LGC Limited (UK) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Creative Bioarray (US) Corporate Information, Head Office, and Major Competitors
Table 51. Creative Bioarray (US) Major Business
Table 52. Creative Bioarray (US) Pharmacokinetics Services Product and Solutions
Table 53. Creative Bioarray (US) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Certara, L.P. (Germany) Corporate Information, Head Office, and Major Competitors
Table 55. Certara, L.P. (Germany) Major Business
Table 56. Certara, L.P. (Germany) Pharmacokinetics Services Product and Solutions
Table 57. Certara, L.P. (Germany) Pharmacokinetics Services Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Pharmacokinetics Services Revenue (USD Million) by Players (2019-2021)
Table 59. Global Pharmacokinetics Services Revenue Share by Players (2019-2021)
Table 60. Breakdown of Pharmacokinetics Services by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Pharmacokinetics Services Players Head Office, Products and Services Provided
Table 62. Pharmacokinetics Services Mergers & Acquisitions in the Past Five Years
Table 63. Pharmacokinetics Services New Entrants and Expansion Plans
Table 64. Global Pharmacokinetics Services Revenue (USD Million) by Type (2016-2021)
Table 65. Global Pharmacokinetics Services Revenue Share by Type (2016-2021)
Table 66. Global Pharmacokinetics Services Revenue Forecast by Type (2021-2026)
Table 67. Global Pharmacokinetics Services Revenue by Application (2016-2021)
Table 68. Global Pharmacokinetics Services Revenue Forecast by Application (2021-2026)
Table 69. North America Pharmacokinetics Services Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Pharmacokinetics Services Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Pharmacokinetics Services Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Pharmacokinetics Services Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Pharmacokinetics Services Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Pharmacokinetics Services Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Pharmacokinetics Services Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Pharmacokinetics Services Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Pharmacokinetics Services Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Pharmacokinetics Services Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Pharmacokinetics Services Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Pharmacokinetics Services Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Pharmacokinetics Services Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Pharmacokinetics Services Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Pharmacokinetics Services Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Pharmacokinetics Services Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Pharmacokinetics Services Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Pharmacokinetics Services Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Pharmacokinetics Services Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Pharmacokinetics Services Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Pharmacokinetics Services Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Pharmacokinetics Services Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Pharmacokinetics Services Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Pharmacokinetics Services Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Pharmacokinetics Services Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Pharmacokinetics Services Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Pharmacokinetics Services Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Pharmacokinetics Services Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Pharmacokinetics Services Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Pharmacokinetics Services Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Pharmacokinetics Services Picture
Figure 2. Global Pharmacokinetics Services Revenue Market Share by Type in 2020
Figure 3. Small Molecules Pharmacokinetics Services
Figure 4. Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Figure 5. Pharmacokinetics Services Revenue Market Share by Application in 2020
Figure 6. Small & Medium Enterprise Picture
Figure 7. Large Enterprise Picture
Figure 8. Global Pharmacokinetics Services Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Pharmacokinetics Services Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Pharmacokinetics Services Revenue Market Share by Region (2016-2026)
Figure 11. Global Pharmacokinetics Services Revenue Market Share by Region in 2020
Figure 12. North America Pharmacokinetics Services Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Pharmacokinetics Services Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Pharmacokinetics Services Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Pharmacokinetics Services Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Pharmacokinetics Services Market Drivers
Figure 17. Pharmacokinetics Services Market Restraints
Figure 18. Pharmacokinetics Services Market Trends
Figure 19. Evotec AG (Germany) Recent Developments and Future Plans
Figure 20. Pacific BioLabs (US) Recent Developments and Future Plans
Figure 21. GVK Biosciences Private Limited (India) Recent Developments and Future Plans
Figure 22. Shanghai Medicilon Inc. (China) Recent Developments and Future Plans
Figure 23. Pharmaceutical Product Development, LLC (US) Recent Developments and Future Plans
Figure 24. Charles River Laboratories International, Inc. (US) Recent Developments and Future Plans
Figure 25. PAREXEL International Corporation (US) Recent Developments and Future Plans
Figure 26. Eurofins Scientific, Inc. (Luxembourg) Recent Developments and Future Plans
Figure 27. Frontage Labs (US) Recent Developments and Future Plans
Figure 28. SGS SA (Switzerland) Recent Developments and Future Plans
Figure 29. LGC Limited (UK) Recent Developments and Future Plans
Figure 30. Creative Bioarray (US) Recent Developments and Future Plans
Figure 31. Certara, L.P. (Germany) Recent Developments and Future Plans
Figure 33. Global Pharmacokinetics Services Revenue Share by Players in 2020
Figure 34. Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Pharmacokinetics Services Revenue Market Share in 2020
Figure 36. Global Top 10 Players Pharmacokinetics Services Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Pharmacokinetics Services Revenue Share by Type in 2020
Figure 39. Global Pharmacokinetics Services Market Share Forecast by Type (2021-2026)
Figure 40. Global Pharmacokinetics Services Revenue Share by Application in 2020
Figure 41. Global Pharmacokinetics Services Market Share Forecast by Application (2021-2026)
Figure 42. North America Pharmacokinetics Services Sales Market Share by Type (2016-2026)
Figure 43. North America Pharmacokinetics Services Sales Market Share by Application (2016-2026)
Figure 44. North America Pharmacokinetics Services Revenue Market Share by Country (2016-2026)
Figure 45. United States Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Pharmacokinetics Services Sales Market Share by Type (2016-2026)
Figure 49. Europe Pharmacokinetics Services Sales Market Share by Application (2016-2026)
Figure 50. Europe Pharmacokinetics Services Revenue Market Share by Country (2016-2026)
Figure 51. Germany Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Pharmacokinetics Services Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Pharmacokinetics Services Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Pharmacokinetics Services Revenue Market Share by Region (2016-2026)
Figure 59. China Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Pharmacokinetics Services Sales Market Share by Type (2016-2026)
Figure 66. South America Pharmacokinetics Services Sales Market Share by Application (2016-2026)
Figure 67. South America Pharmacokinetics Services Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Pharmacokinetics Services Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Pharmacokinetics Services Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Pharmacokinetics Services Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Pharmacokinetics Services Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の薬物動態市場規模・現状・予測（2021年-2027年） Pharmacokinetics is a branch of pharmacology dedicated to determining the fate of substances administered to a living organism. Pharmacokinetics describes how the body affects a specific chemical after administration through the mechanisms of absorption and distribution, as well as the metabolic cha…- 世界の合成子分子市場 2021：企業別、地域別、種類・用途別 The Synthetic Small Molecules market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- 世界の小分子標的がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Cancer Therapy Market The global Small Molecule Targeted Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis a…
- 世界のバイオ医薬品における使い捨て技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Single Use Technologies for Biopharmaceuticals Market The global Single Use Technologies for Biopharmaceuticals market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accura…
- 世界の小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…